Zevra Therapeutics, Inc. (ZVRA)
11.65
-0.22
(-1.85%)
USD |
NASDAQ |
Aug 24, 16:00
11.66
+0.01
(+0.09%)
After-Hours: 20:00
Zevra Therapeutics Total Assets (Quarterly) : 302.71M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 302.71M |
| March 31, 2026 | 278.58M |
| December 31, 2025 | 284.73M |
| September 30, 2025 | 270.12M |
| June 30, 2025 | 256.28M |
| March 31, 2025 | 172.71M |
| December 31, 2024 | 178.13M |
| September 30, 2024 | 191.55M |
| June 30, 2024 | 144.41M |
| March 31, 2024 | 151.28M |
| December 31, 2023 | 172.33M |
| September 30, 2023 | 138.98M |
| June 30, 2023 | 105.52M |
| March 31, 2023 | 106.60M |
| December 31, 2022 | 115.34M |
| September 30, 2022 | 119.55M |
| June 30, 2022 | 124.26M |
| March 31, 2022 | 125.71M |
| December 31, 2021 | 132.94M |
| September 30, 2021 | 137.19M |
| June 30, 2021 | 138.80M |
| March 31, 2021 | 90.44M |
| December 31, 2020 | 11.21M |
| September 30, 2020 | 11.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 12.33M |
| March 31, 2020 | 8.885M |
| December 31, 2019 | 10.51M |
| September 30, 2019 | 12.89M |
| June 30, 2019 | 13.01M |
| March 31, 2019 | 19.87M |
| December 31, 2018 | 26.75M |
| September 30, 2018 | 18.74M |
| June 30, 2018 | 34.00M |
| March 31, 2018 | 42.65M |
| December 31, 2017 | 52.46M |
| September 30, 2017 | 59.31M |
| June 30, 2017 | 69.05M |
| March 31, 2017 | 75.64M |
| December 31, 2016 | 84.89M |
| September 30, 2016 | 94.54M |
| June 30, 2016 | 104.63M |
| March 31, 2016 | 111.94M |
| December 31, 2015 | 55.72M |
| September 30, 2015 | 61.42M |
| June 30, 2015 | 66.54M |
| March 31, 2015 | 14.12M |
| December 31, 2014 | 13.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Innoviva, Inc. | 1.703B |
| Collegium Pharmaceutical, Inc. | 2.136B |
| Johnson & Johnson | 201.06B |
| Ligand Pharmaceuticals, Inc. | 2.186B |
| Harrow, Inc. | 416.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 85.06M |
| Shareholders Equity (Quarterly) | 217.65M |
| Debt to Equity Ratio | 0.0069 |
| Current Ratio | 5.167 |
| Net Debt Paydown Yield | 1.42% |